AT 969

FEATURE

NICOTINE POUCHES

42 ASIAN TRADER 19 SEPTEMBER 2025

altering how these products can

be marketed and sold.

The legislation will ban all

advertising and sponsorship of

vapes and nicotine products,

including nicotine pouches,

whilst closing existing loopholes

to ensure all such products

cannot be sold to

under-18s. Addition­

ally, the bill prohibits

free distribution of

these products and

their sale from

vending machines,

requiring retailers to

adapt their sales strategies

accordingly.

Perhaps most significantly for

the convenience sector, ministers

will gain powers to regulate the

flavours, packaging, and display of

nicotine products, along with

authority to amend product

standards as needed. These

provisions could substantially

impact the category’s current

growth drivers, particularly the

flavour innovation that has

proven so popular with consum­

ers.

Phil Hudson, Associate

Director of the Global Institute

for Novel Nicotine (GINN), argues

for a more nuanced regulatory

approach based on scientific

evidence.

“Public perception of nicotine

has long been clouded by

misconceptions and stigma, often

confusing the substance itself

with the harmful effects of

smoking,” Hudson recently told

Asian Trader.

“A fundamental distinction

needs to be emphasised: nicotine

itself is not the primary cause of

smoking-related diseases. The

dangerous health impacts come

from combustion; the burning of

tobacco that releases thousands

of toxic compounds including

tar and carbon monoxide.”

This distinction is crucial for

retailers engaging with

consumers who may have

questions about nicotine

pouches. The products repre­

sent a fundamental shift in

nicotine delivery – eliminating

combustion entirely and, with

it, many of the health risks

associated with traditional

tobacco products.

Hudson positions nicotine in

a more familiar context:

“Nicotine is essentially a mild

stimulant with effects compara­

ble to caffeine. While it does have

addictive properties, nicotine is

not responsible for the cancers,

heart conditions, or respiratory

diseases associated with smok­

ing.”

He notes that

nicotine occurs

naturally in several

everyday foods,

including tomatoes,

potatoes, and

eggplants – with

research suggesting

these common foods can

contribute up to 2.25 micrograms

of nicotine to daily dietary intake.

“This highlights a crucial

point: the delivery method

determines the risk, not the

nicotine itself. Smoke is the

danger, and not nicotine,”

Hudson points out.

Besides, nicotine pouches are

among the most promising

developments in nicotine replace­

ment therapy (NRT) – tobacco-

free, smoke-free oral products

that deliver nicotine without

combustion.

“The harm reduction potential

of these products is considerable.

However, regulations based on

outdated assumptions or

misconceptions risk limiting this

potential and discouraging

smokers from adopting safer

alternatives,” Hudson warns.

International data strongly

supports harm reduction

approaches. Sweden provides a

compelling example, where

widespread adoption of non-

combustible nicotine products

has contributed to Europe’s

lowest smoking rates and related

mortality.

Smoking prevalence across the

long-term harm reduction.”

The regulatory changes

present both challenges and

opportunities for retailers. Whilst

advertising restrictions may limit

promotional activities, they could

also level the playing field by

reducing marketing spend

requirements. The focus on

product standards and youth

prevention measures may

actually strengthen consumer

confidence in regulated products.

Future perfect

The trajectory for nicotine

pouches appears exceptionally

positive, with all indicators

pointing towards continued

strong growth. The category

benefits from regulatory

advantages over other

nicotine products,

consumer acceptance

of reduced-risk

alternatives, and the

practical advantages of

discrete, smoke-free

consumption.

“The category is

continuing to go from strength to

strength, with increased uptake

from current smokers and vapers,

who are looking for a product that

is more discreet and can be used

almost anywhere,” observes

McGeough.

Success in this dynamic catego­

ry would require a commitment

to variety, proper product

placement, staff training, and

partnership with suppliers who

can provide ongoing support and

education.

As the UK continues its

journey towards a smoke-free

future, nicotine pouches are

positioned to play an increasingly

important role. Retailers who act

now to establish strong positions

in this category are likely to reap

the benefits as the market

continues its impressive

expansion trajectory.

country went down to 5.3 per cent,

according to the health data

released by Sweden’s public health

agency in November last year, but

the figure is just 4.5 per cent

among the nation’s Swedish-born

adults – significantly below the

globally recognised benchmark of

5 per cent for smoke free status.

Commenting at the time, Dr.

Delon Human, leader of Smoke

Free Sweden campaign group,

said the Swedes’ extraordinary

success is the result of their

pioneering policy approach to

safer alternatives to cigarettes.

“In the early 1960s, nearly half

of Swedish men smoked. By

embracing and encouraging the

use of alternative nicotine

products such as snus, oral

nicotine pouches and vapes,

Sweden has paved a clear

path to a smoke-free

society while

safeguarding public

health,” Dr. Human

said, adding: “They

should serve as a beacon

of hope for the rest of the

world and as inspirational proof

that a pragmatic, enlightened

approach can deliver sensational

public health gains and save lives.”

Hudson noted that this

pragmatic, outcome-focused

approach offers valuable lessons

for nations seeking to reduce

smoking prevalence through

means beyond prohibition.

“Treating modern novel nico­

tine products in the same way

the same as traditional tobacco

not only misinforms consumers

but also impedes innovation and

public health progress,” he says.

“Policy frameworks should

reflect the scientific consensus

that nicotine products carry

different levels of risk. This

differentiation is essential to

provide adult smokers with

viable alternatives that support

both cessation efforts and